Pathologigal aspects of prostate cancer and benign nodular hyperplasia

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 2907-2910

  Wernert, Nicolas ^a,b   Bieroff, Erhardt ^a   Hügel, Anja ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NONE   (Germany)

Author keywords

Benign nodular hylerplasia; Histogenesis; Prostate cancer; Tumor suppressor genes

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ESTROGEN RECEPTOR; KERATIN; MICROSATELLITE DNA; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ALLELE; BASAL CELL; BASAL CELL CARCINOMA; CANCER GRADING; CHROMOSOMAL LOCALIZATION; CONFERENCE PAPER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOID CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MESENCHYME; MOLECULAR WEIGHT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATE TUMOR; SECRETORY CELL; SQUAMOUS CELL CARCINOMA; STEM CELL; TUMOR SUPPRESSOR GENE; UROGENITAL TRACT TUMOR; ARTICLE; CHEMISTRY; GENETICS; METABOLISM; PATHOLOGY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0030610822     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Fleming WH, Hamel A, MacDonald R, Ramsey E, Pettigrew NM, Johnston B, Dodd JG, Matusik RJ: Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res 46: 1535-1538, 1986.
2. Viola MV, Fromowik F, Oravez S, Deb S, Finkel G, Lindy J, Hand P, Thor A, Schlom J: Expression of ras oncogene p21, in prostate cancer. N Engl J Med 314: 133-137, 1986.
3. Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA: Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate 11: 327-337, 1987.
4. Strohmeyer T, Effert P: Das Prostatakarzinom: zytogenetische und molekularbiologische Grundlagen. Medizinische Klinik 88: 482-484, 1993.
5. Kallakury BVS, Figge J, Ross JS, Fisher HAG, Figge HL, Jennings TA: Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma. Hum Pathol 25: 92-97, 1994.
6. Shurbaji MS, Kalbfleisch JH, Thurmond TS: Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer. Hum Pathol 26: 106-109, 1995.
7. Gao X, Porter AT, Honn KV: Tumor suppressor genes and their involvement in human prostate cancer: Review. Cancer Molecular Biology 2: 475-498, 1995.
8. Dhom G, Degro S: Therapy of prostatic cancer and histopathologic follow-up. Prostate 3: 531-542, 1982.
9. Reischauer F: Die Entstehung der sogenannten Prostatahypertrophie. Virchows Arch (Path. Anat.) 256: 357-389, 1925.
10. McNeal JE: Pathology of benign prostatic hyperplasia. Insight into etiology. Urol Clin N Am 17: 477-486, 1990.
11. Aumüller G, Goebel HW, Bacher M, Eicheler W, Rausch U: Aktuelle morphologische und funktionelle Aspekte der Prostata. Verh Dtsch Ges Path 77: 1-18, 1993.
12. Cunha GR: Role of mesenchymal epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74: 1030-1044, 1994.
13. Wernert N, Dhom G: Morphologie und Differentialdiagnose der cribriformen Prostatahyperplasie. Pathologe 5: 27-32, 1984.
14. Bostwick DG, Qian J: Atypical adenomatous hyperplasia of the prostate. Am. J. Surg. Pathol.19: 506-518, 1995.
15. Wicke W, Petersen 1, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hummerich J, Muller D, Stangl AP, Schramm J, Wiestler OD, v.Deimling A: Evidence of a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene (in press).
16. Bocking A, Sommerkamp H: Histologisches Malignitäts-Grading des Prostatacarcinoms. Prognostische Validität, Reproduzierbarkeit und Reprasentativität. Verh. Dtsch. Ges Urol 32: 63-65, 1980.
17. Wernert N, Lüchtrath H, Seeliger H, Schäfer M, Goebbels R, Dhom G: Papillary carcinoma of the prostate, location, morphology, and immunohistochemistry: the histogenesis and entity of so-called endometrioid carcinoma. Prostate 10: 123-131, 1987
18. Wernert N: Immunhistochemie der Prostata und des Prostatakarzinoms. Neue Aspekte der Histogenese. Immunohistochemistry of the prostate and prostate carcinoma. New aspects of histogenesis. In: Veröffentlichungen aus der Pathologie, Progress in Pathology, 135 (Dhom G, Eder M, Fischer R, Holzner H, Lennert K, Seifert G, Thoenes W, eds). Gerhard Seifert (Schriftleitung, Editor) Gustav Fischer Verlag, Stuttgart, New York, 1991.
19. Wernert N and Seitz G: Prostatic Cancer - Immunohistochemistry of steroid hormone receptors. In: Current Topics in Pathology. Volume "Cell Receptors - Morphological Characterization and Pathological Aspects" (Seifert G, ed) Springer Verlag, Berlin, Heidelberg, New York, London, Paris, Tokyo, 1991, pp 475-494.
20. Bierhoff E, Vogel J, Benz M, Giefer T, Wernert N, Pfeifer U: Stromal nodules in benign prostatic hyperplasia. Eur Urol (in press).
21. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HFM, Schaafsma HE, Debruyne FMJ, Isaacs WB: Expression of the cellular adhesion molecule E-Cadherin is redduced of absent in high-grade prostate cancer. Cancer Res 52: 5104-5109, 1992.
22. Wernert N, Seitz G, Achtstätter TH: Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract 182: 617-626, 1987.
23. Bonkhoff H, Remberger K: Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch. A (Pathol. Anat) 422: 35-38, 1993.
24. Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dhom G: Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch A 412: 387-391, 1988.
25. Wernert N, Kern L, Heitz PH, Bonkhoff H, Goebbels R, Seitz G, Inniger R, Remberger K, Dhom G: Morphological and immunohistochemical investigations of the utriculus prostaticus from the fetal period up to adulthood. Prostate 17: 19-30, 1990.